| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2018-01-26 | HARVARD MANAGEMENT CO INC | ADURO BIOTECH, INC. | 4,172,449 | 5.4% | EDGAR |
| SC 13G/A | 2018-01-17 | SINGER JAMES R | ADURO BIOTECH, INC. | 6,846,000 | 8.9% | EDGAR |
| SC 13G/A | 2017-12-19 | NOVARTIS AG | ADURO BIOTECH, INC. | 3,170,528 | 4.1% | EDGAR |
| SC 13D/A | 2017-09-15 | Morningside Venture (VI) Investments Ltd | ADURO BIOTECH, INC. | 9,305,532 | 12.5% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | ADURO BIOTECH, INC. | 2,850,547 | 4.2% | EDGAR |
| SC 13G/A | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | ADURO BIOTECH, INC. | 8,656,759 | 12.9% | EDGAR |
| SC 13G | 2017-01-10 | SINGER JAMES R | ADURO BIOTECH, INC. | 3,362,000 | 5.0% | EDGAR |
| SC 13G | 2016-11-10 | WELLINGTON MANAGEMENT GROUP LLP | ADURO BIOTECH, INC. | 7,267,268 | 11.2% | EDGAR |
| SC 13G | 2016-02-12 | FMR LLC | ADURO BIOTECH, INC. | 6,089,062 | 9.6% | EDGAR |
| SC 13G | 2016-02-12 | JOHNSON & JOHNSON | ADURO BIOTECH, INC. | 3,906,207 | 6.2% | EDGAR |
| SC 13G | 2015-04-28 | NOVARTIS AG | ADURO BIOTECH, INC. | 3,170,528 | 5.2% | EDGAR |
| SC 13D | 2015-04-24 | Morningside Venture (VI) Investments Ltd | ADURO BIOTECH, INC. | 19,805,532 | 32.6% | EDGAR |